Elizabeth J. Junor

Edinburgh, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.

Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 17, 2020

Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience.

Clinical outcomes of adenoid cystic carcinoma of the head and neck: a single institution 20-year experience.

Journal: The Journal of laryngology and otology

Published: June 09, 2016

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

Journal: The New England journal of medicine

Published: March 24, 2016

Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.

Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.

Journal: Genes, chromosomes & cancer

Published: March 23, 2016

HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.

HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.

Journal: Cancer research

Published: March 05, 2016

Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.

Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.

Journal: Head & neck

Published: September 25, 2015

Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.

Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.

Journal: Journal of clinical pathology

Published: February 10, 2015

Treatment, comorbidity and survival in stage III laryngeal cancer.

Treatment, comorbidity and survival in stage III laryngeal cancer.

Journal: Head & neck

Published: December 13, 2013

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx.

Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx.

Journal: British journal of cancer

Published: December 08, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026